Annual Current Assets
$38.44 M
-$21.56 M-35.93%
31 December 2023
Summary:
Lineage Cell Therapeutics annual total current assets is currently $38.44 million, with the most recent change of -$21.56 million (-35.93%) on 31 December 2023. During the last 3 years, it has fallen by -$5.56 million (-12.63%). LCTX annual current assets is now -65.54% below its all-time high of $111.55 million, reached on 31 December 2021.LCTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$34.40 M
-$5.99 M-14.83%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly total current assets is currently $34.40 million, with the most recent change of -$5.99 million (-14.83%) on 30 September 2024. Over the past year, it has dropped by -$9.08 million (-20.88%). LCTX quarterly current assets is now -69.16% below its all-time high of $111.55 million, reached on 31 December 2021.LCTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.9% | -20.9% |
| 3 y3 years | -12.6% | -49.7% |
| 5 y5 years | +5.7% | -44.1% |
LCTX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.5% | at low | -69.2% | at low |
| 5 y | 5 years | -65.5% | +5.7% | -69.2% | at low |
| alltime | all time | -65.5% | >+9999.0% | -69.2% | >+9999.0% |
Lineage Cell Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.40 M(-14.8%) |
| June 2024 | - | $40.39 M(-11.7%) |
| Mar 2024 | - | $45.72 M(+18.9%) |
| Dec 2023 | $62.58 M(-1.7%) | $38.44 M(-11.6%) |
| Sept 2023 | - | $43.48 M(-10.3%) |
| June 2023 | - | $48.49 M(-2.3%) |
| Mar 2023 | - | $49.66 M(-17.2%) |
| Dec 2022 | $63.66 M(+1.1%) | $60.00 M(-12.4%) |
| Sept 2022 | - | $68.51 M(-7.5%) |
| June 2022 | - | $74.03 M(-9.6%) |
| Mar 2022 | - | $81.87 M(-26.6%) |
| Dec 2021 | $63.00 M(-1.5%) | $111.55 M(+63.2%) |
| Sept 2021 | - | $68.34 M(-4.5%) |
| June 2021 | - | $71.58 M(+10.8%) |
| Mar 2021 | - | $64.62 M(+46.9%) |
| Dec 2020 | $63.95 M(-5.9%) | $44.00 M(+10.7%) |
| Sept 2020 | - | $39.74 M(-14.0%) |
| June 2020 | - | $46.20 M(-11.6%) |
| Mar 2020 | - | $52.28 M(-9.1%) |
| Dec 2019 | $67.96 M(+4.1%) | $57.52 M(-6.6%) |
| Sept 2019 | - | $61.59 M(+201.0%) |
| June 2019 | - | $20.46 M(-33.3%) |
| Mar 2019 | - | $30.66 M(-15.7%) |
| Dec 2018 | $65.30 M(-50.0%) | $36.36 M(-1.5%) |
| Sept 2018 | - | $36.91 M(+7.0%) |
| June 2018 | - | $34.49 M(-4.5%) |
| Mar 2018 | - | $36.13 M(-15.2%) |
| Dec 2017 | $130.62 M(+11.7%) | $42.62 M(+83.5%) |
| Sept 2017 | - | $23.23 M(-9.0%) |
| June 2017 | - | $25.52 M(-12.8%) |
| Mar 2017 | - | $29.26 M(+14.1%) |
| Dec 2016 | $116.92 M(+146.6%) | $25.65 M(-27.0%) |
| Sept 2016 | - | $35.15 M(+13.2%) |
| June 2016 | - | $31.05 M(-5.7%) |
| Mar 2016 | - | $32.91 M(-30.3%) |
| Dec 2015 | $47.42 M(+11.6%) | $47.24 M(+37.5%) |
| Sept 2015 | - | $34.37 M(-7.1%) |
| June 2015 | - | $37.00 M(+29.6%) |
| Mar 2015 | - | $28.54 M(-11.9%) |
| Dec 2014 | $42.50 M(-14.6%) | $32.41 M(+226.0%) |
| Sept 2014 | - | $9.94 M(-46.7%) |
| June 2014 | - | $18.65 M(+101.7%) |
| Mar 2014 | - | $9.25 M(+16.3%) |
| Dec 2013 | $49.78 M(+120.6%) | $7.95 M(-8.4%) |
| Sept 2013 | - | $8.68 M(-52.1%) |
| June 2013 | - | $18.13 M(+39.8%) |
| Mar 2013 | - | $12.97 M(+80.6%) |
| Dec 2012 | $22.57 M(+8.1%) | $7.18 M(-26.4%) |
| Sept 2012 | - | $9.75 M(-33.3%) |
| June 2012 | - | $14.61 M(-21.7%) |
| Mar 2012 | - | $18.64 M(-25.3%) |
| Dec 2011 | $20.87 M(+17.9%) | $24.96 M(-12.6%) |
| Sept 2011 | - | $28.56 M(-2.9%) |
| June 2011 | - | $29.42 M(-9.8%) |
| Mar 2011 | - | $32.61 M(-8.3%) |
| Dec 2010 | $17.70 M(+1558.7%) | $35.57 M(+33.2%) |
| Sept 2010 | - | $26.71 M(+40.7%) |
| June 2010 | - | $18.99 M(+66.6%) |
| Mar 2010 | - | $11.40 M(-7.8%) |
| Dec 2009 | $1.07 M(+15.2%) | $12.37 M(+50.9%) |
| Sept 2009 | - | $8.20 M(+72.9%) |
| June 2009 | - | $4.74 M(+628.6%) |
| Mar 2009 | - | $650.40 K(+497.2%) |
| Dec 2008 | $926.60 K | $108.90 K(+15.9%) |
| Sept 2008 | - | $94.00 K(-71.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2008 | - | $327.20 K(-38.0%) |
| Mar 2008 | - | $528.10 K(+273.0%) |
| Dec 2007 | $33.50 K(+5.3%) | $141.60 K(+334.4%) |
| Sept 2007 | - | $32.60 K(-80.9%) |
| June 2007 | - | $170.30 K(-49.1%) |
| Mar 2007 | - | $334.80 K(-45.9%) |
| Dec 2006 | $31.80 K(+16.9%) | $618.70 K(-23.9%) |
| Sept 2006 | - | $812.90 K(-26.8%) |
| June 2006 | - | $1.11 M(-36.1%) |
| Mar 2006 | - | $1.74 M(-10.1%) |
| Dec 2005 | $27.20 K(-4.9%) | $1.93 M(+257.2%) |
| Sept 2005 | - | $540.70 K(-22.8%) |
| June 2005 | - | $700.20 K(-15.0%) |
| Mar 2005 | - | $823.30 K(-44.9%) |
| Dec 2004 | $28.60 K(-55.7%) | $1.49 M(-6.8%) |
| Sept 2004 | - | $1.60 M(-24.4%) |
| June 2004 | - | $2.12 M(-5.0%) |
| Mar 2004 | - | $2.23 M(+121.3%) |
| Dec 2003 | $64.50 K(-43.4%) | $1.01 M(-17.4%) |
| Sept 2003 | - | $1.22 M(+69.3%) |
| June 2003 | - | $720.30 K(-45.5%) |
| Mar 2003 | - | $1.32 M(-4.4%) |
| Dec 2002 | $114.00 K(-36.4%) | $1.38 M(-24.6%) |
| Sept 2002 | - | $1.83 M(+213.6%) |
| June 2002 | - | $584.50 K(-47.1%) |
| Mar 2002 | - | $1.11 M(-37.3%) |
| Dec 2001 | $179.20 K(-24.2%) | $1.76 M(-19.5%) |
| Sept 2001 | - | $2.19 M(+381.3%) |
| June 2001 | - | $454.80 K(-32.3%) |
| Mar 2001 | - | $671.90 K(-53.4%) |
| Dec 2000 | $236.50 K(-15.1%) | $1.44 M(-30.0%) |
| Sept 2000 | - | $2.06 M(-18.9%) |
| June 2000 | - | $2.54 M(-32.9%) |
| Mar 2000 | - | $3.78 M(-29.9%) |
| Dec 1999 | $278.60 K(+33.0%) | $5.40 M(-19.4%) |
| Sept 1999 | - | $6.70 M(-17.3%) |
| June 1999 | - | $8.10 M(-11.0%) |
| Mar 1999 | - | $9.10 M(+160.0%) |
| Dec 1998 | $209.50 K(-30.2%) | - |
| Sept 1998 | - | $3.50 M(-18.6%) |
| June 1998 | - | $4.30 M(-20.4%) |
| June 1998 | $300.00 K(+200.0%) | - |
| Mar 1998 | - | $5.40 M(-18.2%) |
| Dec 1997 | - | $6.60 M(-12.0%) |
| Sept 1997 | - | $7.50 M(-8.5%) |
| June 1997 | $100.00 K(0.0%) | $8.20 M(+7.9%) |
| Mar 1997 | - | $7.60 M(+245.5%) |
| Dec 1996 | - | $2.20 M(-8.3%) |
| Sept 1996 | - | $2.40 M(-17.2%) |
| June 1996 | $100.00 K(0.0%) | $2.90 M(0.0%) |
| Sept 1995 | - | $2.90 M(-17.1%) |
| June 1995 | $100.00 K(0.0%) | $3.50 M(-12.5%) |
| Mar 1995 | - | $4.00 M(-11.1%) |
| Dec 1994 | - | $4.50 M(-16.7%) |
| Sept 1994 | - | $5.40 M(-6.9%) |
| June 1994 | $100.00 K(>+9900.0%) | $5.80 M(-9.4%) |
| Mar 1994 | - | $6.40 M(+137.0%) |
| Dec 1993 | - | $2.70 M(-22.9%) |
| Sept 1993 | - | $3.50 M(0.0%) |
| June 1993 | $0.00(0.0%) | $3.50 M(-7.9%) |
| Mar 1993 | - | $3.80 M(-7.3%) |
| Dec 1992 | - | $4.10 M(-6.8%) |
| Sept 1992 | - | $4.40 M(-8.3%) |
| June 1992 | $0.00 | $4.80 M(-7.7%) |
| Mar 1992 | - | $5.20 M |
FAQ
- What is Lineage Cell Therapeutics annual total current assets?
- What is the all time high annual current assets for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual current assets year-on-year change?
- What is Lineage Cell Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly current assets year-on-year change?
What is Lineage Cell Therapeutics annual total current assets?
The current annual current assets of LCTX is $38.44 M
What is the all time high annual current assets for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual total current assets is $111.55 M
What is Lineage Cell Therapeutics annual current assets year-on-year change?
Over the past year, LCTX annual total current assets has changed by -$21.56 M (-35.93%)
What is Lineage Cell Therapeutics quarterly total current assets?
The current quarterly current assets of LCTX is $34.40 M
What is the all time high quarterly current assets for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly total current assets is $111.55 M
What is Lineage Cell Therapeutics quarterly current assets year-on-year change?
Over the past year, LCTX quarterly total current assets has changed by -$9.08 M (-20.88%)